Featured
Featured
Coronavirus: Technopath offers employers not-for-profit antibody tests. By The Irish Times.
Continue Reading
We wish to advise you that our manufacturing and business operations are proceeding as normal and we have implemented measures to ensure the safety of all our staff members. We do not anticipate disruption to our customer service at this time.
Coronavirus: Technopath offers employers not-for-profit antibody tests. By The Irish Times.
Technopath Clinical Diagnostics expands its portfolio of third-party quality control solutions for COVID-19 as clinical laboratories globally ramp up antibody testing
Technopath Clinical Diagnostics USA has been awarded a group purchasing agreement for Quality Control material with Premier Inc.
Technopath Clinical Diagnostics' pioneering technology for the treatment of COVID-19 infected medical waste is fast-tracked for immediate use at New York's largest health care provider
Technopath Clinical Diagnostics and Data Innovations announce partnership to deliver IAMQC® data management solutions with market-leading lab enablement solution Instrument Manager.
Today, we are thrilled to unveil our new website – an important milestone in our continuous efforts to make our products and services ever more accessible and easy to use.
Technopath Clinical Diagnostics and NRL Australia Announce Their Strategic Partnership.
Subscribe to our newsletter for the latest updates
Be one of the first to get latest news and updates from Technopath Clinical Diagnostics straight to your inbox.